These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1795588)

  • 1. Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report.
    Zaheer SA; Suresh NR; Kar HK; Sharma AK; Mukherjee A; Mukherjee R; Talwar GP
    Lepr Rev; 1991 Sep; 62(3):297-302. PubMed ID: 1795588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment: 'Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report'.
    Sehgal VN; Bhattacharya SN; Jain S
    Lepr Rev; 1992 Mar; 63(1):88-9. PubMed ID: 1569824
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized lepromatous leprosy and its response to chemo-immunotherapy.
    Beena KR; Zaheer SA; Guleria I; Mukherjee R; Talwar GP; Mukherjee A; Ramesh V; Misra RS
    Int J Dermatol; 1994 Jan; 33(1):64-7. PubMed ID: 8112948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy.
    Zaheer SA; Mukherjee R; Ramkumar B; Misra RS; Sharma AK; Kar HK; Kaur H; Nair S; Mukherjee A; Talwar GP
    J Infect Dis; 1993 Feb; 167(2):401-10. PubMed ID: 8421173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
    Kar BR; Job CK
    Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment.
    Sharma P; Misra RS; Kar HK; Mukherjee A; Poricha D; Kaur H; Mukherjee R; Rani R
    Lepr Rev; 2000 Jun; 71(2):179-92. PubMed ID: 10920613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculoid relapse in lepromatous leprosy.
    Waters MF; Ridley DS
    Lepr Rev; 1990 Dec; 61(4):353-65. PubMed ID: 2280657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
    Lakshmi C; Srinivas CR
    Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological changes with combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy.
    Natarajan M; Katoch K; Bagga AK; Katoch VM
    Acta Leprol; 1992; 8(2):79-86. PubMed ID: 1293915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
    Shetty VP; Mistry NF; Wakade AV; Ghate SD; Capadia GD; Pai VV
    Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.